MYDA Advisors’s Pfizer PFE Stock Holding History

MYDA Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-60,000	Closed	-$1.74M	–	183
2024 Q3	$1.74M	Buy	60,000 +20,000	+50%	+$583K	0.38%	57
2024 Q2	$1.12M	Hold	40,000	–	–	0.24%	70
2024 Q1	$1.11M	Buy	+40,000	New	+$1.11M	0.32%	62

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

MYDA Advisors's PFE Position: Q3 2025 in Review

MYDA Advisors sold out of Pfizer (PFE) in Q3 2025, closing a stake of 100,000 shares — an estimated $2.42M sold.

MYDA Advisors first reported a position in PFE in Q3 2020 and held it in 7 quarters. The position peaked at $4.05M in Q3 2024. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

MYDA Advisors reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
MYDA Advisors sold 100,000 Pfizer shares in Q3 2025, an estimated $2.42M.
MYDA Advisors first reported a position in Pfizer in Q3 2020 and held it in 7 quarters.
MYDA Advisors's Pfizer position peaked at $4.05M in Q3 2024.
2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on MYDA Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.